Pure Tested Peptides
puretestedpeptides.com
Email me when this record changes
Following this record emails you when it gains a dated entry or its published claims are re-read, and nothing about any other supplier. No topic below is ticked: tick one only if you also want it in the same email.
Compiled automatically from the dated observations in this vendor's record. How we evaluate.
Never merged into one number. Some supplier links here are referral links, marked where they appear, which pay Terminus Research when a reader buys. The same terms are open to every supplier in the ledger, apart from the one exception the referral policy page names, participation changes no score, rank, caution, or coverage decision, and a link is not an endorsement.
Pure Tested Peptides' own linked Certificate of Analysis for the 10mg retatrutide vial sold at $114.99 reports total peptide mass of 7.52 mg, 75.18 percent of label, even as the purity of the material present reads 99.92 percent by HPLC-UV/MS. The certificate's named lab, Krause Analytical, has no live website, while its Finnrick verification line points to a public database that independently rates this vendor, though not on retatrutide: three peptides score 37, 51, and 44 percent against Finnrick's default standard, and four of seven published tests fail. The compound is never named retatrutide in visible product copy, appearing as GLP3-Reta, GLP-3 R or GLP 3 RT, the name confined to blog titles, SEO paragraphs and one molecular-structure note. Has any past buyer weighed their vial's contents against the label, given the vendor's own certificate shows a quarter of the mass missing?
What the record holds
STATED WINDOW IN DAYS
“orders are typically processed within 1-2 business days and usually arrive within 5 days, all orders ship via UPS”
Quoted from the FAQ in the dated entry. Ship-to is answered on the same FAQ page as United States only. The processing and arrival figures are hedged as typically and usually, so under the weaker-when-ambiguous rule the record classes as a stated window rather than a same-or-next-day commitment.
Read from this supplier's own pages on 2026-08-26. This publication has never placed an order with any supplier. This row records what is written and measures nothing about what actually happens after an order.
$114.99
Compound retatrutide 10mg
Listed as Sold under the name GLP3-Reta / GLP-3 R, never as retatrutide in visible product copy; the 10mg option on /product/glp3-reta-10mg/, SKU 'GLP3- 10MG', a single vial, not a kit
Price as recorded $114.99 for one 10mg vial, shown as a sale price against a struck-through regular price of $129.00, read from the product page's own WooCommerce variation data on 2026-08-26. Automatic bulk-discount tiers above the single unit: 3 percent off at 3 units, 4 percent at 4 to 5, 6 percent at 6 to 9, 10 percent at 10 to 14, 15 percent at 15 or more. The vendor's own linked Certificate of Analysis for this product reports only 7.52 mg of actual peptide mass against the 10mg label (75.18 percent of label); full detail in the entries above.
Read on 2026-08-26. One reading on one day, and prices are not tracked over time here.
This supplier was not part of the Trustpilot reading of 2026-08-25, which covered 59 of the 126 suppliers on file. That is a fact about this publication's coverage, stated rather than left to be read either way.
2 claims from this publication's own dossier on this supplier were read again against the live site on 2026-08-26: 1 held, 1 corrected before publication.
A corrected claim is an error of ours that the re-read caught before it reached a page. This line tracks this publication's own accuracy. It says nothing about the supplier.
Dated entries
4 observations on file, recorded 2026-08-26. Newest first, appended and never rewritten.
Certificates read directly from the images the site itself links, not from the catalogue's summary text. The compound is never called retatrutide in visible product copy anywhere on the site; every catalogue listing, category name and product title uses GLP3-Reta, GLP-3 R or GLP 3 RT instead, and the word retatrutide surfaces only inside blog-post titles, SEO body paragraphs and a molecular-structure paragraph citing development code LY3437943. The 10mg product page at /product/glp3-reta-10mg/ links a single COA image, captioned COA can be viewed here, hosted at /wp-content/uploads/2026/02/GLP-3-reta-COA-test.jpeg. Opened directly: a Finnrick Testing Certificate, Test Certificate ID xy6yxvm, verify line reading verify at https://finnrick.com/verify, co-branded with a Krause Analytical logo, lab address Austin, TX, project 135282, lab number 128490, dated 9/12/2025 sample received and 9/18/2025 report issued, sample described as Retatrutide 10 mg XY6YXVM. Two lines matter most: chromatographic purity 99.92 percent by HPLC-UV/MS, and total peptide mass 7.52 mg against the label, printed on the document's own percent-of-label column as 75.180000. So the vendor's own linked certificate for the product priced and sold as a 10mg vial reports the vial actually contains about three quarters of its labelled peptide mass, even though the fraction of material present that is Retatrutide reads a purity in the high nineties. Signed by Mark C. Krause, Laboratory Director. Separately, the site's own central COA library at /coa/ lists retatrutide under two further, non-matching lot references: Reta GLP3 2026 under Lot 05012026, and GLP-3 Reta - Certificate Of Analysis under LOT# 20250915; neither lot label appears anywhere on the XY6YXVM document actually linked from the 10mg product page, so at least three uncorrelated retatrutide lot identifiers circulate across the site.
On lab verifiability, exercised two ways today. First, the certificate's laboratory name: krauseanalytical.com does not serve a laboratory site. Verified twice independently: a raw TLS connection to the domain fails outright (openssl reports an unexpected EOF during the handshake, meaning nothing answers as a normal HTTPS host), and a plain HTTP request to the same domain returns a bare 404. DNS for the domain resolves to the 216.239.32.21 to 216.239.38.21 block, Google's parking range for domains without a configured site, not to any laboratory's own infrastructure. Second, the certificate brand: Finnrick Analytics, at www.finnrick.com, is live and is a real independent testing and vendor-rating operation, 9,991 published lab tests as of today's fetch, public per-peptide and per-vendor leaderboards, and an explicit house rule stated on its own Company page: vendor-submitted samples are labeled as such, and vendor-supplied COAs do not drive the rankings. I queried Finnrick's own public page for this exact vendor, finnrick.com/vendors/pure-tested-peptides, live today. It states plainly that Finnrick has published 7 independent lab tests of 3 peptides from Pure Tested Peptides, naming only CJC-1295, PT-141 and Tesamorelin, rated 37 percent, 51 percent and 44 percent respectively under Finnrick's own default public standard (a purity floor of 99.5 percent by HPLC and a fill window of plus or minus 35 percent of label), with 3 of the 7 tests passing and 4 failing. Retatrutide is not among the three peptides Finnrick's own database credits to this vendor at all, so the Finnrick-branded retatrutide certificate the product page links does not correspond to any entry in Finnrick's own public, queryable record for Pure Tested Peptides.
Benchmark and prices read on 2026-08-26 from /product/glp3-reta-10mg/ and its own WooCommerce variation payload. Retatrutide (GLP3-Reta) is sold as a single vial, not a kit; the 10mg option, SKU recorded on the page as GLP3- 10MG, carries a display price of $114.99 against a struck display_regular_price of $129.00. Two further single-vial sizes sit on the same product: 20MG at $179.99 (regular $199.00), SKU GLP-3 R 20MG, and 30MG at $199.99 (regular $229.00), SKU GLP3-R 30MG. Automatic bulk-discount tiers apply to the 10mg vial above the base unit price of $114.99: 3 percent off at 3 units ($111.54 each), 4 percent at 4 to 5 ($110.39), 6 percent at 6 to 9 ($108.09), 10 percent at 10 to 14 ($103.49), 15 percent at 15 or more ($97.74). Payment methods, quoted from the FAQ page in full: credit, debit, plaid ACH, crypto, Cashapp, venmo, and more. Shipping, quoted from the FAQ: orders are typically processed within 1-2 business days and usually arrive within 5 days, all orders ship via UPS. Ship-to is answered directly on the same FAQ page under the heading Do You Offer International Shipping: No. We currently only ship to the United States. Entity and contact: the only location claim found anywhere fetched today is the FAQ's own line, We are proudly located in the USA!, with no city, state or street address given on the About page, the Contact page, or the footer; the phone number given sitewide, 727-513-9780, carries a Florida area code, while the Privacy Policy's own governing-law clause names the State of Texas and any dispute is to be filed in a Texas state or federal court. Contact channels given are phone/SMS at that number and email at sales@puretestedpeptides.com.
CAUTIONCautions noted, each tied to a page fetched today. First and most direct: the vendor's own linked Certificate of Analysis for the 10mg product it sells at $114.99 reports a total peptide mass of 7.52 mg against the 10mg label, which the document itself expresses as 75.180000 percent of label, while the purity of the material actually present reads 99.92 percent by HPLC-UV/MS; the number that matters for what a buyer receives per vial is the fill figure, not the purity figure, and the two point in different directions. Second, that same certificate's named laboratory, Krause Analytical, has no live website at krauseanalytical.com today (documented above with two independent checks), so the entity behind the signature on the document could not be reached to confirm its own claims. Third, the Finnrick brand under which the certificate is issued independently tests and rates this exact vendor on its own public site, and rates it poorly: 37 percent, 51 percent and 44 percent across the three peptides it has actually tested from this vendor (CJC-1295, PT-141, Tesamorelin), with 4 of 7 published tests failing Finnrick's own default standard; retatrutide is not one of the tested peptides in that public record at all. Fourth, the About page states its six biomedical credentials (CBET, CCE, RAC, CQE/CBA, CRES, CHTM) are, quoted verbatim, held by named members of our quality, regulatory affairs, and operations teams, yet the same page names zero individual people anywhere; every credential is attributed only to an unnamed our-X-certified role. Fifth, the Privacy Policy identifies itself by its own text as a RocketLawyer.com document and still carries an unreplaced template placeholder, quoted verbatim, referring to DGD pages, or register with DGD site or services, rather than to Pure Tested Peptides or PTP anywhere in that sentence. Sixth, the compound is marketed throughout under euphemistic names (GLP3-Reta, GLP-3 R, GLP 3 RT) with retatrutide itself confined to back-end SEO copy and metadata, the same pattern flagged at other vendors this wave. Seventh, at least three non-matching lot identifiers for retatrutide circulate across the site's own pages, documented above, with no single lot number reconciling the product page's linked certificate against the central COA library's own listings.
Reader reviews
No reader review of this supplier is published yet. Every review is read and checked against the record before it appears. Add a review.
Open this supplier
Some supplier links here are referral links, marked where they appear, which pay Terminus Research when a reader buys. The same terms are open to every supplier in the ledger, apart from the one exception the referral policy page names, participation changes no score, rank, caution, or coverage decision, and a link is not an endorsement.